+148.5%
MRNA vs OMC
-3.6%
+152.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | OMC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | +1.5% | -0.7% | -0.3% |
| 7D | -8.2% | -6.2% | -2.0% | -4.1% |
| 30D | +125.6% | -7.6% | +133.1% | +139.2% |
| 3M | +197.1% | +7.4% | +189.7% | +196.5% |
| 6M | +148.5% | +0.1% | +148.3% | +172.8% |
| All | +148.5% | -3.6% | +152.1% | +172.8% |
Cumulative growth
Daily Returns
Daily percentage return beside OMC.
Daily Out/Under-Performance
Portfolio return minus OMC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × OMC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded OMC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling